Evidence map›Paper›PMID 41745742›Full record

ArticleToxins2026

Squeeze-Excitation Attention-Guided 3D Inception ResNet for Aflatoxin B1 Classification in Almonds Using Hyperspectral Imaging.

Md Ahasan Kabir, Ivan Lee, Sang-Heon Lee

Abstract read
In one paragraph

Article in Toxins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Md Ahasan KabirUniSA STEM, University of South Australia, Mawson Lakes, SA 5095, Australia.ORCID 0000-0002-3382-0799
Ivan LeeUniSA STEM, University of South Australia, Mawson Lakes, SA 5095, Australia.ORCID 0000-0002-2826-6367
Sang-Heon LeeUniSA STEM, University of South Australia, Mawson Lakes, SA 5095, Australia.ORCID 0000-0002-3655-7981

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Almonds are a highly valued nut due to their rich protein and nutritional content. However, they are vulnerable to aflatoxin B1 (AFB1) contamination in warm and humid environments. Consumption of AFB1-contaminated almonds can pose serious health risks, including kidney damage, and may lead to significant economic losses. Consequently, a rapid and non-destructive detection method is essential to ensure food safety by identifying and removing contaminated almonds from the supply chain. Hyperspectral imaging (HSI) and 3D deep learning provide a non-destructive, efficient alternative to current AFB1 detection methods. This study presents an attention-guided Inception ResNet 3D Network (AGIR-3DNet) for fast and precise detection of AFB1 contamination in almonds utilizing HSI. The proposed model integrates multi-scale feature extraction, residual learning, and attention mechanisms to enhance spatial-spectral feature representation, enabling more precise classification. The proposed 3D model was rigorously tested, and its performance was compared against 3D Inception and various conventional machine learning models. Compared to conventional machine learning models and deep learning architectures, AGIR-3DNet outperformed and achieved superior validation accuracy of 93.30%, an F1-score (harmonic mean of precision and recall) of 0.94, and an area under the receiver operating characteristic curve (AUC) value of 0.98. Furthermore, the model enhances processing efficiency, making it faster and more suitable for real-time industrial applications.

Indexed as

aflatoxin B1attention guided deep neural networkattention mechanismhyperspectral imaginginception ResNetsqueeze-excitation attention

Identifiers

PMID41745742
PMCPMC12944700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.